Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial
BACKGROUND: In a previous UK multi-center randomized study 278 children received three doses of 7-valent (PCV-7) or 13-valent (PCV-13) pneumococcal conjugate vaccine at 2, 4 and 12 months of age. At 13 months of age, most of these children had pneumococcal serotype-specific IgG concentrations ≥ 0.35...
Main Authors: | Trück, J, Snape, MD, Tatangeli, F, Voysey, M, Yu, L, Faust, SN, Heath, P, Finn, A, Pollard, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2014
|
Similar Items
-
Persistent circulation of vaccine serotypes and serotype replacement after 5 years of infant immunization with 13-valent pneumococcal conjugate vaccine in the United Kingdom
by: Kandasamy, R, et al.
Published: (2019) -
The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy.
by: Trück, J, et al.
Published: (2016) -
Divergent Memory B Cell Responses in a Mixed Infant Pneumococcal Conjugate Vaccine Schedule
by: Trück, J, et al.
Published: (2016) -
Differences in immunization site pain in toddlers vaccinated with either the 10- or the 13-valent pneumococcal conjugate vaccine
by: Trück, J, et al.
Published: (2018) -
Sex-dependent immune responses to infant vaccination: An individual participant data meta-analysis of antibody and memory B cells
by: Voysey, M, et al.
Published: (2016)